Press Releases

LOUISVILLE, Ky. and TAMPA, Fla., Nov. 4, 2019 /PRNewswire/ -- WellCare of Kentucky, a WellCare Health Plans, Inc. (NYSE: WCG) company, announced it has signed an agreement with Owensboro Health, a nonprofit health system headquartered in Owensboro, Kentucky, to continu

BEIJING, Nov. 4, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its third quarter 2019 financial results on Wednesday, November 13, 2019 after the market closes.

--- FreshDirect founder and former CEO Jason Ackerman joins Board of Directors and named Executive Chairman --- Heather Molloy promoted to Chief Strategy Officer--- Strong revenue growth with $26 million preliminary unaudited Q3 revenue, nearly 50% higher than Q2, and

SAN DIEGO, Nov. 4, 2019 /PRNewswire/ -- Agena Bioscience, a global provider of molecular testing solutions, today announced the release of the VeriDose™ CYP2D6 CNV panel designed to provide PGx testing programs with a more accurate and efficient way to analyze CYP2D6 copy number. The RUO panel quantifies CYP2D6 copy number, even in the presence of CYP2D6/CYP2D

SAN DIEGO, Nov. 4, 2019 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of molecular offerings designed to provide physicians with clinically actionable informa

REHOVOT, Israel, and BRIDGEWATER, N.J., Nov. 4, 2019 /PRNewswire/ -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (Foamix or the Company), a specialty pharmaceutical company, announced today the peer review publication of the long term open label safety portions of studies FX2014-04 and FX2014-05 (Studies 04 & 05) in the

BRIDGEWATER, N.J., Nov. 4, 2019 /PRNewswire/ -- Cosette Pharmaceuticals, Inc., a generic pharmaceutical company primarily focused on extended topical and suppository products, announced today that it has purchased G&W Laboratories' finished dosage manufacturing plant located in Lincolnton, NC."The purchase of the

NEW YORK, Nov. 4, 2019 /PRNewswire/ -- CannRx, a company developing proprietary, scientifically based medical and recreational products, today announced that the Company's Founder and Chief Scientific Offi

BOSTON, Nov. 4, 2019 /PRNewswire/ -- Entrada Therapeutics, a biotechnology company dedicated to transforming the treatment of devastating diseases through the intracellular delivery of biologics, today announced the appointment of Nathan J. Dowden as Chief Operating Officer. Mr. Dowden was most recently Senior Vice President of Strateg

WALTHAM, Mass., Nov. 4, 2019 /PRNewswire/ -- Fresenius Medical Care North America's Renal Therapies Group, the leading provider of kidney care products, today announced the